Patents-Review.com
ClassID:

110026 ⎘

C12N2710/24161 - CPC Classification

Classification description:

dsDNA viruses; Details; Poxviridae; Orthopoxvirus, e.g. vaccinia virus, variola Methods of inactivation or attenuation

Sub-classes:
Recent Application in this class:
#1
20230310526
2023-10-05

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

 #2
20220339221
2022-10-27

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

 #3
20200237839
2020-07-30

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy

 #4
20200108136
2020-04-09

Methods and compositions for live attenuated viruses

 #5
20190054131
2019-02-21

Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human Flt3L or GM-CSF for cancer immunotherapy

 #6
20170100474
2017-04-13

Methods and compositions for live attenuated viruses

 #7
20170095552
2017-04-06

Microorganisms for therapy

 #8
20140294891
2014-10-02

Microorganisms for therapy

 #9
20130183271
2013-07-18

Methods and compositions concerning poxviruses and cancer

 #10
20120276010
2012-11-01

Microorganisms for therapy

 #11
20120183574
2012-07-19

MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCNATION OF NEONATES

 #12
20110300176
2011-12-08

Microorganisms for therapy

 #13
20110171256
2011-07-14

Viral strains derived from the vaccinia virus Lister VACV-107 and uses thereof

 #14
20110135683
2011-06-09

Modified Vaccinia Virus Ankara for the vaccination of neonates

 #15
20100062016
2010-03-11

Microorganisms for therapy

 #16
20100016224
2010-01-21

COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE

 #17
20100008946
2010-01-14

Microorganisms for therapy

 #18
20090324548
2009-12-31

Vaccinia Virus Strains

 #19
20090169512
2009-07-02

Vaccinia virus strains

 #20
20090143289
2009-06-04

Orthopoxvirus vectors, genes and products thereof

 #21
20090136917
2009-05-28

Systems and methods for viral therapy

 #22
20090110694
2009-04-30

Anti-Inflammatory Proteins and Improved Vaccines

 #23
20090104224
2009-04-23

Modified vaccinia virus ankara for the vaccination of neonates

 #24
20090004723
2009-01-01

Methods and compositions concerning poxviruses and cancer

 #25
20080248551
2008-10-09

Methods and compositions for live attenuated viruses

 #26
20070212727
2007-09-13

Microorganisms for therapy

 #27
20070202572
2007-08-30

Microorganisms for therapy

 #28
20070025981
2007-02-01

Microorganisms for therapy

 #29
20060153873
2006-07-13

Smallpox vaccine

 #30
20060099224
2006-05-11

Methods and compositions concerning poxviruses and cancer

 #31
20060099181
2006-05-11

Viral vectors having reduced virulence

 #32
20060051370
2006-03-09

Microorganisms for therapy

 #33
20050163805
2005-07-28

Orthopoxvirus vectors, genes and products thereof

 #34
20050042206
2005-02-24

Viral vectors having reduced virulence

 #35
20050031643
2005-02-10

Microorganisms for therapy